422 related articles for article (PubMed ID: 10644903)
1. Hypoparathyroidism potentiates cardiovascular complications through disturbed calcium metabolism: possible risk of vitamin D(3) analog administration in dialysis patients with end-stage renal disease.
Tsuchihashi K; Takizawa H; Torii T; Ikeda R; Nakahara N; Yuda S; Kobayashi N; Nakata T; Ura N; Shimamoto K
Nephron; 2000 Jan; 84(1):13-20. PubMed ID: 10644903
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
3. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
4. Are we overconcerned about secondary hyperparathyroidism and underestimating the more common secondary hypoparathyroidism in our dialysis patients?
Jeloka T; Mali M; Jhamnani A; Konde S; Jadhav V
J Assoc Physicians India; 2012 Feb; 60():102-5. PubMed ID: 22715556
[TBL] [Abstract][Full Text] [Related]
5. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
[TBL] [Abstract][Full Text] [Related]
6. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?
Raggi P; Boulay A; Chasan-Taber S; Amin N; Dillon M; Burke SK; Chertow GM
J Am Coll Cardiol; 2002 Feb; 39(4):695-701. PubMed ID: 11849871
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
Qunibi WY; Nolan CA; Ayus JC
Kidney Int Suppl; 2002 Dec; (82):S73-80. PubMed ID: 12410860
[TBL] [Abstract][Full Text] [Related]
9. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
[TBL] [Abstract][Full Text] [Related]
10. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Galassi A; Spiegel DM; Bellasi A; Block GA; Raggi P
Nephrol Dial Transplant; 2006 Nov; 21(11):3215-22. PubMed ID: 16877490
[TBL] [Abstract][Full Text] [Related]
11. Postoperative hypoparathyroidism after thyroidectomy: efficient and cost-effective diagnosis and treatment.
Selberherr A; Scheuba C; Riss P; Niederle B
Surgery; 2015 Feb; 157(2):349-53. PubMed ID: 25532435
[TBL] [Abstract][Full Text] [Related]
12. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
13. The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping.
Xu H; Peng W; Yang Z; Zhang Y; Xia C; Li Z; Xu R; Guo Y
J Cardiovasc Magn Reson; 2021 Mar; 23(1):23. PubMed ID: 33691727
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of parathyroid dysfunction in elderly patients on hemodialysis.
Lu JR; Yi Y; Tian J; Xiong CX; Wang XH; Hu J; Chen XF
Blood Purif; 2014; 37(2):119-24. PubMed ID: 24662249
[TBL] [Abstract][Full Text] [Related]
15. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
17. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure.
Fernández E; Fibla J; Betriu A; Piulats JM; Almirall J; Montoliu J
J Am Soc Nephrol; 1997 Oct; 8(10):1546-52. PubMed ID: 9335382
[TBL] [Abstract][Full Text] [Related]
18. Secondary hyperparathyroidism and risk factors in patients undergoing peritoneal dialysis in a tertiary hospital.
Suwan N
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S101-5. PubMed ID: 22043575
[TBL] [Abstract][Full Text] [Related]
19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
20. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
